Pfizer and Allogene in Cancer Therapy Pact

06.04.2018 - Pfizer and Allogene have entered into an agreement to develop allogeneic chimeric antigen receptor T cell (CAR T) therapy for treating cancer. The deal will see Pfizer take a 25%...